Inactivation of foot-and-mouth disease virus A/IRN/8/2015 with commercially available lysis buffers
Open Access
- 1 April 2020
- journal article
- research article
- Published by Elsevier BV in Journal of Virological Methods
- Vol. 278, 113835
- https://doi.org/10.1016/j.jviromet.2020.113835
Abstract
No abstract availableKeywords
Funding Information
- Department for Environment, Food and Rural Affairs, UK Government
This publication has 18 references indexed in Scilit:
- Effective Chemical Inactivation of Ebola VirusEmerging Infectious Diseases, 2016
- Buffer AVL Alone Does Not Inactivate Ebola Virus in a Representative Clinical Sample TypeJournal of Clinical Microbiology, 2015
- Correction for LaRocco et al., A Continuous Bovine Kidney Cell Line Constitutively Expressing Bovine α V β 6 Integrin Has Increased Susceptibility to Foot-and-Mouth Disease VirusJournal of Clinical Microbiology, 2015
- The economic impacts of foot and mouth disease – What are they, how big are they and where do they occur?Preventive Veterinary Medicine, 2013
- A Continuous Bovine Kidney Cell Line Constitutively Expressing Bovine αVβ6Integrin Has Increased Susceptibility to Foot-and-Mouth Disease VirusJournal of Clinical Microbiology, 2013
- Chemical disinfection of high-consequence transboundary animal disease viruses on nonporous surfacesBiologicals, 2011
- Inactivation of orthopoxvirus for diagnostic PCR analysisJournal of Virological Methods, 2007
- Virus inactivation by nucleic acid extraction reagentsJournal of Virological Methods, 2004
- Foot-and-Mouth DiseaseClinical Microbiology Reviews, 2004
- Routine application of enzyme-linked immunosorbent assay in comparison with complement fixation for the diagnosis of foot-and-mouth and swine vesicular diseasesVeterinary Microbiology, 1988